Two Sigma Advisers’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Buy |
+41,280
| New | +$12.3K | ﹤0.01% | 2294 |
|
|
2023
Q2 | – | Sell |
-2,740
| Closed | -$9.32K | – | 2546 |
|
|
2023
Q1 | $9.32K | Sell |
2,740
-26,810
| -91% | -$91.2K | ﹤0.01% | 2544 |
|
|
2022
Q4 | $133K | Sell |
29,550
-11,860
| -29% | -$53.4K | ﹤0.01% | 2258 |
|
|
2022
Q3 | $364K | Sell |
41,410
-34,150
| -45% | -$300K | ﹤0.01% | 1974 |
|
|
2022
Q2 | $869K | Sell |
75,560
-31,220
| -29% | -$359K | ﹤0.01% | 1667 |
|
|
2022
Q1 | $1.87M | Sell |
106,780
-45,880
| -30% | -$803K | 0.01% | 1296 |
|
|
2021
Q4 | $4.95M | Buy |
152,660
+113,380
| +289% | +$3.67M | 0.01% | 772 |
|
|
2021
Q3 | $1.58M | Buy |
39,280
+6,395
| +19% | +$256K | ﹤0.01% | 1383 |
|
|
2021
Q2 | $539K | Sell |
32,885
-31,455
| -49% | -$516K | ﹤0.01% | 1917 |
|
|
2021
Q1 | $1.22M | Buy |
64,340
+8,000
| +14% | +$152K | ﹤0.01% | 1540 |
|
|
2020
Q4 | $1.27M | Sell |
56,340
-170
| -0.3% | -$3.83K | ﹤0.01% | 1462 |
|
|
2020
Q3 | $1.12M | Buy |
56,510
+53,780
| +1,970% | +$1.06M | ﹤0.01% | 1454 |
|
|
2020
Q2 | $57K | Buy |
+2,730
| New | +$57K | ﹤0.01% | 2415 |
|